openPR Logo
Press release

Neuromodulation Market (By Application, Technology, Region and Company) and Forecast to 2021 – Global Analysis

10-04-2016 01:05 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: DPI Research

neuromodulartion market, neuromodulation

neuromodulartion market, neuromodulation

The Global market for Neuromodulation is projected to reach more than US$5 Billion by the end of 2021 growing at a CAGR of around XX% from 2016 to 2021.

Market growth can be attributed to factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players. In addition, rapid advances in the field of neuromodulation and development of minimally invasive techniques have greatly expanded the market. High cost of treatment and negative social perception is restraining the growth of neuromodulation market.

North America is seen as the dominant player in the neuromodulation market followed by Europe, Asia–Pacific, and rest of the world (RoW) in 2015. In the coming years, the neuromodulation market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of devices involved in neuromodulation.

Spinal cord stimulation segment dominated the neuromodulation market with more than XX% share in 2015. But its market share will dwindle in the forecasting period due to the highest growth rate of deep brain stimulation. It is expected that deep brain stimulation will grasp nearly 20% market share by the year end of 2021.

Chronic Pain is identified as the largest application segment of the neuromodulation market. Urinary and Fecal Incontinence(UFI) is the second leading segment for neuromodulation market. Refractory epilepsy stands at the third spot with more than XX% share in 2015. Parkinson’s disease holds the fourth highest share being followed by Gastroparesis. Essential Tremor and Dystonia are the other leading application segment for neuromodulation market.

Further, prudent analysis has been done on the competitor’s part, where three major players grab XX% of the global market by revenue. Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro are the key influencers with their products in the Neuromodulation market. Merger & acquisitions, partnerships, collaborations and extending distribution networks are few important factors for their dominance.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, application, technology, geographies, companies and competitive landscape. The report concludes with the profiles of major players in the global neuromodulation such as Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro. The major market players are evaluated on various parameters such as company overview, product portfolio, and sales analysis of neuromodulation segment from 2010 to 2021.The report also entails major drivers and challenges of neuromodulation market.

Neuromodulation Market: Segmentation

Neuromodulation market is classified on the basis of technology, application, company and geography.

Based on Technology, Neuromodulation market can be segmented as follows:

Spinal Cord Stimulation

Deep Brain Stimulation

Sacral Nerve Stimulation

Vagus Nerve Stimulation

Other Technologies

Based on Application, Neuromodulation market can be segmented as follows:



Chronic Pain

Parkinson’s Disease

Urinary Fecal Incontinence

Refractory Epilepsy

Essential Tremor

Dystonia

Gastroparesis

Treatment Resistant Depression(TRD)

Obsessive Compulsive Disorder(OCD)

Other Applications

Based on Geography, Neuromodulation market can be segmented as follows:



North America

Europe

Asia Pacific

Latin America

Rest of the World (ROW)

Based on Company, Neuromodulation market can be segmented as follows:



Medtronic

Boston Scientific

St Jude Medical

Liva Nova(Cyberonics)

Nevro

DPI Research & Marketing Solutions
95/9, Kishangarh
Vasant Kunj
New Delhi 110070
India
Contact:Sajid Jamal
Presscontaact:seo@dpiresearch.com

DPI Research & Marketing Solutions
95/9, Kishangarh
Vasant Kunj
New Delhi 110070
India
Contact:Sajid Jamal
Presscontaact:seo@dpiresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuromodulation Market (By Application, Technology, Region and Company) and Forecast to 2021 – Global Analysis here

News-ID: 369098 • Views:

More Releases from DPI Research

United States Ready Meals and Soup Market Worth US$ 82.8 Bn by 2032
United States Ready Meals and Soup Market Worth US$ 82.8 Bn by 2032
The United States ready meals and soup market size was valued at US$ 64.9 billion in 2024 and is likely to reach USD 82.8 billion by 2032, expanding at a CAGR 3% during the forecast period. United States Ready Meals and Soup Market Growth Drivers The United States ready meals and soup market has seen significant growth in recent years. With busy lifestyles and increasing demand for convenience, more consumers are turning
China Neuro-Interventional Device Market Worth 10.2 Bn by 2032
China Neuro-Interventional Device Market Worth 10.2 Bn by 2032
China Neuro-Interventional Device Market Size and Trends China neuro-interventional device market size was valued at USD 2.7 billion in 2024 and is projected to hit around USD 10.2 billion by 2032, growing at a CAGR of 18% during the forecast period 2025 to 2032. China Neuro-Interventional Device Market Growth Drivers The neuro-interventional device market in China is experiencing significant growth, driven by a combination of factors. These specialized devices are pivotal in treating
U.S Continuous Glucose Monitoring (CGM) Market Size to Surpass USD 8.4 Billion by 2033
U.S Continuous Glucose Monitoring (CGM) Market Size to Surpass USD 8.4 Billion b …
Millions of Americans are diagnosed with diabetes each year, leading to a growing need for effective monitoring solutions. United States Continuous Glucose Monitoring (CGM) Market Size and Trends According to the DPI Research, The United States Continuous Glucose Monitoring (CGM) market size was valued at USD 3.7 billion in 2024 and is projected to hit around USD 8.4 billion by 2033, growing at a CAGR of 9.5% during the forecast period 2025
Thailand Meetings, Incentives, Conferences and Exhibitions Market to Reach $13 Bn by 2033 | Exclusive Report by DPI Research
Thailand Meetings, Incentives, Conferences and Exhibitions Market to Reach $13 B …
Thailand Meetings, Incentives, Conferences and Exhibitions Market Size and Trends The Thailand Meetings, Incentives, Conferences, and Exhibitions market was valued at USD 4.3 billion in 2024 and is projected to hit around USD 13 billion by 2033, growing at a CAGR of 10.3% during the forecast period 2025 to 2033. Download Free Sample Report: https://dpiresearch.com/report/thailand-meetings-incentives-conferences-and-exhibitions-market-2025-2033/ Thailand Meetings, Incentives, Conferences and Exhibitions Market Growth Drivers Several elements are driving the market growth of Thailand's MICE

All 5 Releases


More Releases for Neuromodulation

Neuromodulation Market worth $10.4 billion by 2027
Neuromodulation Market is projected to grow from USD 6.0 billion in 2022 to USD 10.4 billion by 2027, at a CAGR of 11.8% from 2022 to 2027, according to a new report by MarketsandMarkets™. The market is driven by government support for research on neurological disorder along with increasing prevalence of neurological disorders. Emerging economies are expected to provide lucrative growth opportunities for the market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=921&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral The internal neuromodulation
Neuromodulation Market worth $11.0 billion by 2028
Browse 195 market data Tables and 39 Figures spread through 210 Pages and in-depth TOC on "Neuromodulation Market by Type (Internal (Spinal Cord Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation), Application (Tremor, Epilepsy, Parkinson's Disease, Depression, Gastroparesis), and Region - Global Forecast to 2028 Neuromodulation Market in terms of revenue was estimated to be worth $6.2 billion in 2023 and is poised to reach $11.0 billion by 2028, growing at
Neuromodulation Market: Charting Future Frontiers for 2030
The Neuromodulation market was valued USD 6.5 Billion in 2023 and projected to reach USD 15.3 Billion by 2030, growing at a CAGR of 13.0% during the forecast period of 2024-2030. The Neuromodulation Market report studies the competitive environment of the Neuromodulation Market based on company profiles and their efforts to increase product value and production. The Neuromodulation Market report discusses various factors driving or restraining the market, which will help
Incontinence Neuromodulation Market - Reclaiming Independence, Redefining Well-b …
Newark, New Castle, USA: The "Incontinence Neuromodulation Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Incontinence Neuromodulation Market: https://www.growthplusreports.com/report/incontinence-neuromodulation-market/8696 This latest report researches the industry structure, sales, revenue,
Neuromodulation Devices Market Insights, Forecast to 2030
The report extensively examines the global Neuromodulation Devices market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Neuromodulation Devices . For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global market
Neuromodulation Market Outlook 2022-2028
Neurological issues are characterized as problems that influence the mind as well as the nerves tracked down all through the human body and the spinal rope. Intense spinal line injury, Alzheimer's sickness, amyotrophic horizontal sclerosis (ALS), ataxia, chime paralysis, mind cancers, cerebral aneurysm, epilepsy, and seizures are a portion of the normal neurological issues. The biochemical, underlying, or electrical irregularities in the mind, spinal line, or different nerves bring about